Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the prior v3.4.1 notice about government funding lapse was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated several footer labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0 replacing v3.3.4). Core study information, eligibility criteria, outcomes, and study timelines remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no substantive user-facing content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing study sites and reorganized location headers; updated to revision v3.3.3 and removed the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check92 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study; updated Revision to v3.3.2. Removed the previous PubMed note stating publications are from PubMed and automatically generated by ClinicalTrials.gov with NCT Number and v3.2.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.